| 01/03/23 | 11:16:50 | 1 Mar 2023 | | Total Voting Rights |
| 20/02/23 | 07:00:05 | 20 Feb 2023 | | Dr Frank Mathias to join as new CEO on 27 March |
| 01/02/23 | 10:18:19 | 1 Feb 2023 | | Total Voting Rights |
| 27/01/23 | 07:00:05 | 27 Jan 2023 | | Board Change |
| 03/01/23 | 17:19:57 | 3 Jan 2023 | | Block listing return |
| 03/01/23 | 11:28:55 | 3 Jan 2023 | | Total Voting Rights |
| 21/12/22 | 12:00:01 | 21 Dec 2022 | | Oxford Biomedica to Present at J.P Morgan |
| 14/12/22 | 07:00:02 | 14 Dec 2022 | | Oxford Biomedica Solutions forms new partnerships |
| 22/11/22 | 07:00:08 | 22 Nov 2022 | | Oxford Biomedica Appoints Frank Mathias as CEO |
| 15/11/22 | 14:35:16 | 15 Nov 2022 | | Holding(s) in Company |
| 14/11/22 | 07:00:06 | 14 Nov 2022 | | Sale and leaseback of Windrush Court facility |
| 01/11/22 | 09:14:18 | 1 Nov 2022 | | Total Voting Rights |
| 14/10/22 | 14:28:51 | 14 Oct 2022 | | PDMR Dealings |
| 12/10/22 | 07:00:06 | 12 Oct 2022 | | PDMR Dealings |
| 12/10/22 | 07:00:06 | 12 Oct 2022 | | PDMR Dealings |
| 07/10/22 | 13:16:49 | 7 Oct 2022 | | PDMR Dealing Amendment |
| 07/10/22 | 12:28:28 | 7 Oct 2022 | | PDMR Dealing |
| 07/10/22 | 07:00:04 | 7 Oct 2022 | | Amendment of Short-Term Loan Facility |
| 03/10/22 | 09:34:18 | 3 Oct 2022 | | Total Voting Rights |
| 15/09/22 | 07:00:14 | 15 Sept 2022 | | Interim Results |
| 14/09/22 | 07:00:12 | 14 Sept 2022 | | Oxford Biomedica Solutions signs new partner |
| 07/09/22 | 07:00:03 | 7 Sept 2022 | | Licence & Supply Agreement with New Partner |
| 01/09/22 | 09:51:09 | 1 Sept 2022 | | Total Voting Rights |
| 25/08/22 | 07:00:04 | 25 Aug 2022 | | Notice of Interim Results |
| 16/08/22 | 07:00:11 | 16 Aug 2022 | | Oxford Biomedica Notes Homology Q2 Report |
| 01/08/22 | 09:42:04 | 1 Aug 2022 | | Total Voting Rights |
| 27/07/22 | 07:00:14 | 27 Jul 2022 | | Appointment of Joint Corporate Broker |
| 26/07/22 | 07:00:08 | 26 Jul 2022 | | Licence & Supply Agreement with New Partner |
| 26/07/22 | 07:00:06 | 26 Jul 2022 | | New Project with Orchard Therapeutics |
| 21/07/22 | 07:00:11 | 21 Jul 2022 | | Expanded Agreement with BMS’s Juno in CAR-T |
| 15/07/22 | 10:13:02 | 15 Jul 2022 | | BLOCK LISTING RETURN |
| 01/07/22 | 09:55:51 | 1 Jul 2022 | | Total Voting Rights |
| 01/07/22 | 07:00:07 | 1 Jul 2022 | | Signs new agreement with AstraZeneca |
| 14/06/22 | 07:00:07 | 14 Jun 2022 | | Notes FDA lift clinical hold on pheNIX trial |
| 01/06/22 | 07:00:07 | 1 Jun 2022 | | Total Voting Rights |
| 27/05/22 | 18:03:06 | 27 May 2022 | | Result of AGM |
| 03/05/22 | 17:18:46 | 3 May 2022 | | Grant of options |
| 03/05/22 | 16:46:23 | 3 May 2022 | | Director/PDMR Shareholding |
| 03/05/22 | 10:35:18 | 3 May 2022 | | Total Voting Rights |
| 29/04/22 | 17:42:43 | 29 Apr 2022 | | Directors Dealings / Market Share Purchases |
| 28/04/22 | 14:24:00 | 28 Apr 2022 | | Director/PDMR Shareholding |
| 27/04/22 | 14:58:02 | 27 Apr 2022 | | 2021 Annual report and accounts & AGM notification |
| 27/04/22 | 12:10:35 | 27 Apr 2022 | | PDMR Dealings / Market Share Purchase |
| 21/04/22 | 16:41:06 | 21 Apr 2022 | | Director Share Purchase |
| 21/04/22 | 13:24:45 | 21 Apr 2022 | | Directors Dealings / Market Share Purchase |
| 21/04/22 | 10:16:17 | 21 Apr 2022 | | Director/PDMR Shareholding |
| 20/04/22 | 15:45:17 | 20 Apr 2022 | | Director/PDMR Shareholding |
| 20/04/22 | 07:00:04 | 20 Apr 2022 | | Preliminary Results |
| 13/04/22 | 07:00:12 | 13 Apr 2022 | | Board Appointment |
| 04/04/22 | 11:34:57 | 4 Apr 2022 | | Notice of Preliminary Results |
